JP
4015 JAMJOOM PHARMAKSA
Everything important about one stock — one page ·
130.10 SAR
-1.14%
Quote 28 Sept 2026, 15:20 KSA
Day move−1.14%
130.10 SAR
Easy Score22
Weak
Indicators3/18
3 bullish · 4 neutral · 11 bearish
Trend — 6 months−10.2%
Down
BullishNeutralBearish
Trend — daily 6 months
Down -10.2% — sellers are in control
Trend — weekly 3 years
Up +14.9% — rising but under its average — momentum cooling
Company financials — direction 2023–2025
| Metric | Then → now | Change | Meaning |
|---|---|---|---|
| Revenue | SAR 1.1B → SAR 1.5B | +36% | the business is growing |
| Net margin | 27% → 31% | +4.3 pts | keeps more of every dollar |
22
Easy Score — Weak
Key indicators — and what each means now 3 bullish / 11 bearish of 18
Bullish 3Neutral 4Bearish 11
| RSI (14) 37 | healthy — not overbought, not oversold | |
| vs 200-day MA -10% | below its long-term average = long-term pressure | |
| MACD bearish | momentum currently favors sellers | |
| Volume 0.3× | normal activity — no unusual crowd behavior | |
| September 3y win rate 67% | September closed green 2 of the last 3 years |
The read
Insufficient profitability data. Daily trend down, weekly trend up. Whole picture, not advice.
Analysis through completed session of 28 Sept, 3:00 am KSA · Full analysis →